Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:13 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | VANGUARD GROUP INC | 8,816,124 9.42% | 782,860 (+9.75%) | View |
2024-02-13 1:34 pm Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | JANUS HENDERSON GROUP PLC JHG | 5,345,785 5.7% | -682,231 (-11.32%) | View |
2024-02-09 6:05 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | Capital International Investors | 4,741,485 5.1% | 4,741,485 (New Position) | View |
2024-01-26 5:26 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | BlackRock Inc. BLK | 6,266,973 6.7% | 709,739 (+12.77%) | View |
2023-02-14 3:23 pm Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | SANDS CAPITAL MANAGEMENT LLC | 2,151,378 2.5% | -3,213,249 (-59.90%) | View |
2023-02-10 11:28 am Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | JANUS HENDERSON GROUP PLC JHG | 6,028,016 6.9% | -1,217,846 (-16.81%) | View |
2023-02-09 11:32 am Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | VANGUARD GROUP INC | 8,033,264 9.15% | -277,844 (-3.34%) | View |
2023-01-31 5:52 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | BlackRock Inc. BLK | 5,557,234 6.3% | 272,000 (+5.15%) | View |
2022-02-11 7:18 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | SANDS CAPITAL MANAGEMENT LLC | 5,364,627 6.16% | 4,387,496 (+449.02%) | View |
2022-02-11 12:13 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | JANUS HENDERSON GROUP PLC JHG | 7,245,862 8.3% | 7,245,862 (New Position) | View |
2022-02-10 08:37 am Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | VANGUARD GROUP INC | 8,311,108 9.54% | 1,093,849 (+15.16%) | View |
2022-02-09 10:24 am Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | FMR LLC | 2,955,056 3.391% | -3,160,172 (-51.68%) | View |
2022-02-01 5:14 pm Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | BlackRock Inc. BLK | 5,285,234 6.1% | -93,981 (-1.75%) | View |
2021-08-10 12:21 pm Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | Capital Research Global Investors | 3,842,491 4.8% | -4,181,639 (-52.11%) | View |
2021-02-16 11:40 am Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | SANDS CAPITAL MANAGEMENT LLC | 977,131 1.24% | -3,580,368 (-78.56%) | View |
2021-02-10 12:30 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | Capital Research Global Investors | 8,024,130 10.2% | 287,382 (+3.71%) | View |
2021-02-10 12:26 pm Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | Capital Research Global Investors | 7,736,748 9.8% | 7,736,748 (New Position) | View |
2021-02-10 11:52 am Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | VANGUARD GROUP INC | 7,217,259 9.15% | 832,471 (+13.04%) | View |
2021-02-08 10:31 am Sale | 13G | SAREPTA THERAPEUTICS INC SRPT | FMR LLC | 6,115,228 7.741% | -2,232,756 (-26.75%) | View |
2021-02-01 08:23 am Purchase | 13G | SAREPTA THERAPEUTICS INC SRPT | BlackRock Inc. BLK | 5,379,215 6.8% | 738,930 (+15.92%) | View |